ClinicalTrials.Veeva

Menu

Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V (REWARDS TLX)

MedStar Health logo

MedStar Health

Status

Completed

Conditions

Coronary Artery Disease

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT01134159
REWARDS TLX

Details and patient eligibility

About

Multicenter, retrospective registry to collect 9-12 month follow-up data to evaluate major adverse cardiac events in patients whom have undergone percutaneous coronary intervention and received either Taxus Liberte or Xience V.

Enrollment

1,200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients 18 years of age or older, both genders
  • Underwent PCI with Taxus Liberte (alone) or Xience (alone)

Exclusion criteria

  • Underwent PCI with a non-Taxus Liberte or Xience V DES during the same procedure
  • Received both Taxus-Liberte and Xience-V during the same index procedure
  • Patients not taking, or unable to take, dual antiplatelet therapy (aspirin plus clopidogrel or prasugrel).

Trial design

1,200 participants in 2 patient groups

Xience V
Description:
Those who have only received a Xience V stent
Taxus Liberte
Description:
Those who have received only a Taxus Liberte stent

Trial contacts and locations

10

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems